Journal article
Cost Effectiveness Analysis of Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for Early Stage Renal Cell Carcinoma (RCC)
Abstract
OBJECTIVES: To conduct a cost-effectiveness analysis of stereotactic body radiotherapy (SBRT) versus radiofrequency ablation (RFA) in the non-surgical management of early stage renal cell carcinoma (RCC) according to Consolidated Health Economic Evaluation Reporting Standards (CHEERS) criteria in the Canadian healthcare system.
METHODS: A Markov state transition model was constructed for initial local treatment with RFA or SBRT for early stage, …
Authors
Donovan EK; Xie F; Louie AV; Chu W; Siva S; Kapoor A; Swaminath A
Journal
Clinical Genitourinary Cancer, Vol. 20, No. 5, pp. e353–e361
Publisher
Elsevier
Publication Date
October 2022
DOI
10.1016/j.clgc.2022.03.011
ISSN
1558-7673